A detailed history of Vident Advisory, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Vident Advisory, LLC holds 19,133 shares of BSX stock, worth $1.46 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
19,133
Previous 16,928 13.03%
Holding current value
$1.46 Million
Previous $979 Million 33.91%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $127,008 - $151,307
2,205 Added 13.03%
19,133 $1.31 Billion
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $46,645 - $55,439
959 Added 6.01%
16,928 $979 Million
Q3 2023

Feb 21, 2024

SELL
$50.19 - $54.68 $48,132 - $52,438
-959 Reduced 5.67%
15,969 $843 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $801,484 - $873,184
15,969 New
15,969 $843 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $109B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.